Lakewood-Amedex Biotherapeutics Inc. Financing Cash Flow
Lakewood-Amedex Biotherapeutics Inc. (LABT) reported Financing Cash Flow of $6.80 million for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-18
- Lakewood-Amedex Biotherapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $6.68M, a 413.62% increase year-over-year.
- Lakewood-Amedex Biotherapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $125.00K, a 37.50% decline year-over-year.
- Lakewood-Amedex Biotherapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was $1.30M.
- Lakewood-Amedex Biotherapeutics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $200.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|
| 2026-06-30 | $6.68M derived: S-1 6 month − 10-Q 3 month · filed 2026-09-18 | $6.80M S-1 · filed 2026-09-18 | |
| 2026-03-31 | $125.00K 10-Q · filed 2026-05-22 | ||
| 2025-12-31 | $1.50M S-1 · filed 2026-09-18 | ||
| 2025-06-30 | $1.30M derived: S-1 6 month − 10-Q 3 month · filed 2026-09-18 | $1.50M S-1 · filed 2026-09-18 | |
| 2025-03-31 | $200.00K 10-Q · filed 2026-05-22 | ||
| 2024-12-31 | -$50.00K S-1 · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B |